Article

AAO's lobbyists called one of most effective

Washington, DC?The American Academy of Ophthalmology's governmental affairs team has been named one of the nine most effective groups to lobby Congress. The AAO's team?led by Catherine Grealy Cohen?was one of only two groups representing a medical specialty included on the list by The Hill newspaper, which focuses on the work of Congress.

Washington, DC-The American Academy of Ophthalmology's governmental affairs team has been named one of the nine most effective groups to lobby Congress. The AAO's team-led by Catherine Grealy Cohen-was one of only two groups representing a medical specialty included on the list by The Hill newspaper, which focuses on the work of Congress.

The article can be found at http:// http://www.hillnews.com/thehill/export/TheHill/Business/020106_lobbyleague.html.

The team plans to tackle several Medicare physician reimbursement issues as its top priority for 2006. Among those challenges are the sustainable growth rate (SGR), pay for performance, and the 5-year review of work values.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.